- Home
- LXEO vs GLO Comparison
LXEO vs GLO Comparison
Compare LXEO & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- GLO
- Stock Information
- Founded
- LXEO 2017
- GLO 2006
- Country
- LXEO United States
- GLO United States
- Employees
- LXEO N/A
- GLO N/A
- Industry
- LXEO
- GLO Finance/Investors Services
- Sector
- LXEO
- GLO Finance
- Exchange
- LXEO Nasdaq
- GLO Nasdaq
- Market Cap
- LXEO 252.4M
- GLO 220.1M
- IPO Year
- LXEO 2023
- GLO N/A
- Fundamental
- Price
- LXEO $6.14
- GLO $5.15
- Analyst Decision
- LXEO Strong Buy
- GLO
- Analyst Count
- LXEO 5
- GLO 0
- Target Price
- LXEO $23.80
- GLO N/A
- AVG Volume (30 Days)
- LXEO 274.8K
- GLO 170.5K
- Earning Date
- LXEO 12-31-2024
- GLO 01-01-0001
- Dividend Yield
- LXEO N/A
- GLO 11.38%
- EPS Growth
- LXEO N/A
- GLO N/A
- EPS
- LXEO N/A
- GLO N/A
- Revenue
- LXEO N/A
- GLO N/A
- Revenue This Year
- LXEO N/A
- GLO N/A
- Revenue Next Year
- LXEO N/A
- GLO N/A
- P/E Ratio
- LXEO N/A
- GLO N/A
- Revenue Growth
- LXEO N/A
- GLO N/A
- 52 Week Low
- LXEO $5.77
- GLO $4.08
- 52 Week High
- LXEO $22.33
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- LXEO 35.77
- GLO 27.44
- Support Level
- LXEO $6.78
- GLO $5.00
- Resistance Level
- LXEO $7.40
- GLO $5.33
- Average True Range (ATR)
- LXEO 0.66
- GLO 0.06
- MACD
- LXEO -0.13
- GLO -0.03
- Stochastic Oscillator
- LXEO 1.34
- GLO 15.23
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return. The fund invests in a mix of U.S. and non-U.S. equity and debt securities.